Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03674567 |
|---|---|
| Brief Title: | Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab |
| First Submitted : | September 14, 2018 |
| First Submitted that Met QC Criteria : | September 14, 2018 |
| First Posted : | September 17, 2018 |
| Last Update Submitted that Met QC Criteria : | April 12, 2024 |
| Last Update Posted : | April 16, 2024 |